Development and Clinical Applications of a Virtual Imaging Framework for Optimizing Photon-counting CT

The purpose of this study was to develop a virtual imaging framework that simulates a new photon-counting CT (PCCT) system (NAEOTOM Alpha, Siemens). The PCCT simulator was built upon the DukeSim platform, which generates projection images of computational phantoms given the geometry and physics of the scanner and imaging parameters. DukeSim was adapted to account for the geometry of the PCCT prototype. To model the photon-counting detection process, we utilized a Monte Carlo-based detector model with the known properties of the detectors. We validated the simulation platform against experimental measurements. The images were acquired at four dose levels (CTDIvol of 1.5, 3.0, 6.0, and 12.0 mGy) and reconstructed with three kernels (Br36, Br40, Br48). The experimental acquisitions were replicated using our developed simulation platform. The real and simulated images were quantitatively compared in terms of image quality metrics (HU values, noise magnitude, noise power spectrum, and modulation transfer function). The clinical utility of our framework was demonstrated by conducting two clinical applications (COPD quantifications and lung nodule radiomics). The phantoms with relevant pathologies were imaged with DukeSim modeling the PCCT systems. Different imaging parameters (e.g., dose, reconstruction techniques, pixel size, and slice thickness) were altered to investigate their effects on task-based quantifications. We successfully implemented the acquisition and physics attributes of the PCCT prototype into the DukeSim platform. The discrepancy between the real and simulated data was on average about 2 HU in terms of noise magnitude, 0.002 mm(-1) in terms of noise power spectrum peak frequency and 0.005 mm(-1) in terms of the frequency at 50% MTF. Analysis suggested that lung lesion radiomics to be more accurate with reduced pixel size and slice thickness. For COPD quantifications, higher doses, thinner slices, and softer kernels yielded more accurate quantification of density-based biomarkers. Our developed virtual imaging platform enables systematic comparison of new PCCT technologies as well as optimization of the imaging parameters for specific clinical tasks.